ibdinfo.no

Jeg er helsepersonell Jeg er ikke helsepersonell

ibdinfo.no

Forlat siden Bli på siden

Myter og fakta om kosthold og IBD

Brosjyren er for deg som har Crohns sykdom eller ulcerøs kolitt.

Referanser

  1. Molodecky, NA. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30.
  2. Jahnsen, J. et al. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002 Feb;37(2):192-9.
  3. Loftus, EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004 May;126(6):1504-17.
  4. Kristensen, V. et al. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin. J Crohns Colitis. 2015 Feb;9(2):164-9
  5. Ponder, A. et al. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013 Jul 25;5:237-47
  6. Ng, SC. Et al. Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD). Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013 Apr;62(4):630-49.
  7. Wu, GD. Et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011 Oct 7;334(6052):105-8.
  8. Lewis, JD. Et al. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology. 2017 Feb;152(2):398-414.e6.
  9. Ryan, E. et al. Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis. 2019 Jan 1;25(1):67-73.
  10. Balestrieri, P. et al. Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients. 2020 Jan 31;12(2):372.
  11. Levine, A. et. al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn’s disease: evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study. Inflamm Bowel Dis. 2014 Feb;20(2):278-85.
  12. The Crohn’s & Colitis Foundation. Malnutrition and IBD. . [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.crohnscolitisfoundation.org/diet-and-nutrition/malnutrition-and-ibd
  13. Levine, A. et al. Effects of enteral nutrition on Crohn’s disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis. 2013 May;19(6):1322-9.
  14. Levine, A. et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019 Aug;157(2):440-450.e8.
  15. Gibson, PR. Et al. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010 Feb;25(2):252-8.
  16. Whelan, K.et al. The Low FODMAP diet in the management of irritable bowel syndrome. An evidence-based review of FODMAP restriction, reintroduction and personalization in clinical practice. J Hum Nutr. Diet, 2018; 31: 239-255
  17. Halpin, S.J. et al.. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J of Gastroenterol. 2012;107 (10): 1474-1482
  18. Limketkai, BN. Et al. Nutritional Interventions in the Patient with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2018 Mar;47(1):155-177.
  19. Pedersen, N. et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017 May 14;23(18):3356-3366.
  20. Gibson, PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:40-42.
  21. Testa, A. et al. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis. 2018;36(4):271-280.
  22. Colombel, JF. Et al. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2019 Feb;17(3):380-390.e1
  23. Zhan, YL. Et al. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review. Clin Nutr. 2018 Feb;37(1):123-129.
  24. Cox ,SR. et al. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis. 2017 Dec 4;11(12):1420-1429.
  25. Gearry, RB. Et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis. 2009 Feb;3(1):8-14.
  26. Prince, AC. Et al. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 May;22(5):1129-36.
  27. Maagaard, L. et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016 Apr 21;22(15):4009-19.
  28. Croagh, C. et al. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis. 2007 Dec;13(12):1522-8.
  29. Halmos, EP. Et al. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn’s Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016 Apr 14;7(4):e164.
  30. Scaldaferri, F. et al. Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract. 2017;2017:8646495.
  31. Gajendran, M. et al.  A comprehensive review and update on Crohn’s disease. Dis Mon. 2018 Feb;64(2):20-57.
  32. Frigstad, SO. Et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.
  33. Moum, B. et al. Seasonal variations in the onset of ulcerative colitis. Gut 1996; 38: 376-378
  34. Zeng, L. et al. Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol. 1996 Jan;31(1):79-82.
  35. Mouli, VP. Et al. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 Jan;39(2):125-36.
  36. Holick, MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81.
  37. Jørgensen, SP. et al. Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013 Nov;7(10):e407-13.
  38. Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.
  39. Raftery, T. et al. Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn’s Disease in Clinical Remission. Dig Dis Sci. 2015 Aug;60(8):2427-35.
  40. Mayur Garg, FRACP. Et al. Association of Circulating Vitamin D Concentrations with Intestinal but Not Systemic Inflammation in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, Volume 19, Issue 12, 1 November 2013, Pages 2634–2643
  41. Blanck, S. et al. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013 Jun;58(6):1698-702.
  42. Kabbani, TA. et al. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol. 2016 May;111(5):712-9.
  43. Mouli, VP. et al. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 Jan;39(2):125-36.
  44. Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.
  45. Nordic Nutrition Recommendations.  Part 3, Vitamins A, D, E, K, Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Biotin, Panthothenic acid and vitamin C. 5th edition; 2012., s 33.
  46. Institute of Medicine (US) Committee to Review. Ross AC, Taylor CL, Yaktine AL, et al., editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. [hentet august 2023 ]. Tilgjengelig fra: https://www.ncbi.nlm.nih.gov/books/NBK56070/
  47. Bager, P. et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011 Mar;46(3):304-9.
  48. Weisshof, R. et al. Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):576-81.
  49. Stein, J. et al. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63.
  50. Stein, J. et al. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):599-610.
  51. Jelsness-Jørgensen, LP. et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011 Jul;17(7):1564-72.
  52. Wells, CW. et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006 Feb;12(2):123-30.
  53. Dignass, AU. et al. European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015 Mar;9(3):211-22.
  54. Vidal-Alaball, J. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004655.
  55. Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321-347.
  56. Norsk legemiddelhåndbok. T4.1.2.1 Vitamin B12-mangel. [publisert 14. jun 2021; hentet 19. jun 2023]. Tilgjengelig fra: www.legemiddelhandboka.no/T4.1.2.1/Vitamin_B12-mangel
  57. Aleksandrova, K. et al. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients. 2017 Aug 30;9(9):962.
  58. Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.
  59. Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf
  60. Solberg IC, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431-40
  61. Solberg IC, et al. Clinical Course in Crohn’s Disease: Results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5(12):1430-1438
  62. Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. s. 180-84, 187-88. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf
  63. Skodje, GI. et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb;154(3):529-539.e2.
  64. Skodje GI. Fruktaner gir symptomer hos personer med selvrapportert ikke-cøliakisk glutensensitivitet – ikke gluten. NGF-Nytt. 2018;1:28
  65. Gibson, PR. et al. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010 Feb;25(2):252-8.
  66. Hou, JK. et al. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr;106(4):563-73.
  67. Daley, CA. et al. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J. 2010 Mar 10;9:10.
  68. John, S. et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010 May;22(5):602-6.
  69. Gallai, V. et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995 Feb;56(2):143-53.
  70. Bergset, T. Mat fra havet mot tarmbetennelse. [Internett]. Tidsskr Nor Legeforen, 2013.; [ hentet 30. juni 2023]. Tilgjengelig fra: https://tidsskriftet.no/2013/05/nyheter/mat-fra-havet-mot-tarmbetennelse
  71. Vasudevan, A.  et al. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer. Cancer Prev Res (Phila). 2014 Nov;7(11):1138-48.
  72. John, S. et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010 May;22(5):602-6.
  73. Gallai, V. et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995 Feb;56(2):143-53.
  74. Bergset, T. Mat fra havet mot tarmbetennelse. [Internett]. Tidsskr Nor Legeforen, 2013.; [ hentet 30. juni 2023]. Tilgjengelig fra: https://tidsskriftet.no/2013/05/nyheter/mat-fra-havet-mot-tarmbetennelse
  75. Helsedirektoratet. Kostrådene. [Internett]. [oppdatert 24. okt 2016; hentet 30 juni 2023]. Tilgjengelig fra: https://www.helsedirektoratet.no/faglige-rad/kostradene-og-naeringsstoffer/kostrad-for-befolkningen
  76. Daley, CA. et al. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J. 2010 Mar 10;9:10.
  77. Roediger, WE. et al. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology. 1993 Mar;104(3):802-9.
  78. Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):10038-43.
  79. Jowett, SL. et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004 Oct;53(10):1479-84.
  80. Albenberg, L. et al. A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares. Gastroenterology. 2019 Jul;157(1):128-136.e5.
  81. Hou, JK. et al. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr;106(4):563-73.
  82. Bernstein, CN. et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006 Jul;101(7):1559-68.)
  83. Sakamoto, N. et al. Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005 Feb;11(2):154-63.
  84. Jantchou, P.et al. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010 Oct;105(10):2195-201.
  85. Pituch-Zdanowska, A. et al. The role of dietary fibre in inflammatory bowel disease. Prz Gastroenterol. 2015;10(3):135-41.
  86. Bowling, TE. et al. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993 Nov 20;342(8882):1266-8.
  87. Spaeth, G. et al. Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg. 1994 Dec;220(6):798-808.
  88. Kleessen, B. et al. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr. 2001 Aug;86(2):291-300.
  89. Inan, MS. et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology. 2000 Apr;118(4):724-34.
  90. Ritchie, JK. et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn’s disease. Br Med J (Clin Res Ed). 1987 Aug 29;295(6597):517-20.
  91. Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. s. 185. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf
  92. NAAF. Hjemmeside. [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.naaf.no/
  93. Riordan AM, et al. A review of associations between Crohn’s disease and consumption of sugars. Eur J Clin Nutr. 1998 Apr;52(4):229-38
  94. Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321-347.
  95. Chassaing, B. et al. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017 Aug;66(8):1414-1427.
  96. Mattilsynet. Hjemmeside [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.mattilsynet.no/